miRNA profile obtained by next-generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments

Metastatic breast cancer (MBC) is a challenge for oncologists, and public efforts should focus on identifying additional molecular markers and therapeutic management to improve clinical outcomes. Among all diagnosed cases of breast cancer (BC; approximately 10%) involve metastatic disease; notably,...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Gutierrez, Antonio Daniel, Catalan, Oliver Millan, Vázquez-Romo, Rafael, Reyes, Fany Iris Porras, Alvarado-Miranda, Alberto, Medina, Fernando Lara, Bargallo-rocha, Juan E., Moreno, Luz Tonatzin Orozco, De León, David Cantú, Herrera, Luis Alonso, López-Camarillo, César, Pérez-Plasencia, Carlos, Campos-parra, Alma D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713405/
https://www.ncbi.nlm.nih.gov/pubmed/31364724
http://dx.doi.org/10.3892/ijmm.2019.4292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713405/
https://www.ncbi.nlm.nih.gov/pubmed/31364724
http://dx.doi.org/10.3892/ijmm.2019.4292

Ejemplares similares